首页> 美国卫生研究院文献>Bulletin of the World Health Organization >Recent progress in the development of malaria vaccines: Memorandum from a WHO Meeting
【2h】

Recent progress in the development of malaria vaccines: Memorandum from a WHO Meeting

机译:疟疾疫苗开发的最新进展:世界卫生组织会议的备忘录

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The sixth meeting of the Scientific Working Group on the Immunology of Malaria reviewed studies on the identification and analysis of malarial antigens of asexual blood stages and sexual stages (gametes, zygotes, ookinetes) that may be exploited as targets for vaccination. Several proteins have been identified on the surface of mature schizonts and free merozoites, some of which can be recognized by antibodies which block in vitro parasite growth. Immunization of rodents and monkeys with purified antigens from the parasite surface membrane has conferred substantial immunity against subsequent challenge. A new class of malarial antigens has been identified which bind specifically to glycophorin, the major erythrocyte glycoprotein; these antigens are on the merozoite surface and it is possible that they mediate attachment to erythrocytes. Antibodies against these proteins also block parasite growth in vitro. The Plasmodium falciparum S-antigens have been characterized biochemically and the genes for two of these proteins sequenced. Several antigens have been localized in the invasion process, and monoclonal antibodies against these proteins block in vitro growth. Malarial antigens on the surface of P. falciparum trophozoite and schizont-infected erythrocytes may be involved in the cytoadherence of infected erythrocytes to endothelial cells. Surface antigens on gametes and zygotes of P. gallinaceum and P. falciparum have been shown to be the targets of transmission-blocking immunity. Monoclonal antibodies specific for these antigens block fertilization in the mosquito midgut. Transmission of P. gallinaceum can also be blocked by an antibody that blocks development of zygotes into ookinetes. Studies on the transmission of P. yoelii have identified a gamete protein that immunizes mice against transmission to mosquitos.
机译:疟疾免疫学科学工作组第六次会议审查了关于鉴定和分析无性血液阶段和性阶段(配子,合子,速动子)的疟疾抗原的研究,这些抗原可被用作疫苗接种的靶标。已经在成熟的裂殖体和游离裂殖子的表面上鉴定了几种蛋白质,其中一些可以被阻断体外寄生虫生长的抗体识别。用来自寄生虫表面膜的纯化抗原对啮齿动物和猴子进行免疫,赋予了抵抗后续攻击的实质性免疫力。已经鉴定出一类新的疟疾抗原,其与主要的红细胞糖蛋白糖蛋白特异性结合。这些抗原在裂殖子表面上,并且有可能介导与红细胞的附着。针对这些蛋白质的抗体在体外也能阻止寄生虫的生长。恶性疟原虫S-抗原已进行了生化鉴定,并对其中两个蛋白质的基因进行了测序。几种抗原已经定位在入侵过程中,针对这些蛋白质的单克隆抗体会阻断体外生长。恶性疟原虫滋养体和裂殖体感染的红细胞表面的疟疾抗原可能与被感染的红细胞对内皮细胞的细胞粘附有关。业已证明,没食子丙酸杆菌和恶性疟原虫的配子和受精卵上的表面抗原是阻断传递免疫的靶标。对这些抗原具有特异性的单克隆抗体会阻断蚊子中肠的受精。鸡油单胞菌的传播也可以通过一种抗体来阻断,该抗体可以阻止受精卵发育为猪胚。关于约氏疟原虫传播的研究已经鉴定出配子蛋白,该配子蛋白使小鼠免疫以抵抗蚊子的传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号